Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large B-Cell, Diffuse × Immune Checkpoint Inhibitors × 30 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 5 Squamous Cell Carcinoma of Head and Neck 2 Solid Cancers 2 Neoplasms 2 Melanoma 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Solid Tumors 1 Small Cell Lung Carcinoma 1 Sarcopenia 1 SCLC 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Oropharyngeal Neoplasms 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Immune-Related Adverse Events 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Cholangiocarcinoma 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Rituximab 19 Cyclophosphamide 19 Prednisone 13 Lenalidomide 11 Doxorubicin 11 Oxaliplatin 9 Gemcitabine 9 fludarabine 8 Specimen Handling 8 Vincristine 7 Magnetic Resonance Spectroscopy 7 polatuzumab vedotin 6 Etoposide 6 glofitamab 5 CT-P10 5 venetoclax 4 obinutuzumab 4 ibrutinib 4 fludarabine phosphate 4 axicabtagene ciloleucel 4 Biopsy 4 deltacortene 3 Prednisolone 3 Leukapheresis 3 Ifosfamide 3 prednylidene 2 pembrolizumab 2 acalabrutinib 2 Whole-Body Irradiation 2 Spinal Puncture 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡